These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 21288688)

  • 21. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B
    Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
    Altun E; Martin DR; Wertman R; Lugo-Somolinos A; Fuller ER; Semelka RC
    Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid deterioration of renal insufficiency after magnetic resonance imaging with gadolinium-based contrast agent.
    Fujisaki K; Ono-Fujisaki A; Kura-Nakamura N; Komune N; Hirakawa N; Tsuruya K; Komune S; Iida M
    Clin Nephrol; 2011 Mar; 75(3):251-4. PubMed ID: 21329636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media.
    Karlsberg RP; Dohad SY; Sheng R;
    J Nephrol; 2010; 23(6):658-66. PubMed ID: 20540038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?
    Nyman U; Elmståhl B; Leander P; Nilsson M; Golman K; Almén T
    Radiology; 2002 May; 223(2):311-8; discussion 328-9. PubMed ID: 11997530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark.
    Elmholdt TR; Pedersen M; Jørgensen B; Søndergaard K; Jensen JD; Ramsing M; Olesen AB
    Br J Dermatol; 2011 Oct; 165(4):828-36. PubMed ID: 21692765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke.
    Sharma J; Nanda A; Jung RS; Mehta S; Pooria J; Hsu DP
    J Neurointerv Surg; 2013 Nov; 5(6):543-5. PubMed ID: 23125428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial.
    Lufft V; Hoogestraat-Lufft L; Fels LM; Egbeyong-Baiyee D; Tusch G; Galanski M; Olbricht CJ
    Am J Kidney Dis; 2002 Aug; 40(2):236-42. PubMed ID: 12148095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is elevated creatinine level a contraindication to endovascular aneurysm repair?
    Mehta M; Veith FJ; Lipsitz EC; Ohki T; Russwurm G; Cayne NS; Suggs WD; Feustel PJ
    J Vasc Surg; 2004 Jan; 39(1):118-23. PubMed ID: 14718828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic systemic fibrosis associated with gadolinium use.
    Chao CC; Yang CC; Hsiao CH; Pan MK; Lin CH; Hsieh ST
    J Formos Med Assoc; 2008 Mar; 107(3):270-4. PubMed ID: 18400614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.
    Kini AS; Sarkar K; Rafael OC; Jakkula M; Kaplish D; Lee P; Suleman J; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):49-55. PubMed ID: 19288579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of nephrogenic systemic fibrosis at a large university hospital in Sweden.
    Alhadad A; Sterner G; Svensson Å; Alhadad H; Leander P
    Scand J Urol Nephrol; 2012 Feb; 46(1):48-53. PubMed ID: 22008005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gadolinium-enhanced thoracic CTA: retrospective analysis of image quality and tolerability in 45 patients evaluated prior to the description of nephrogenic systemic fibrosis].
    Smadja L; Rémy-Jardin M; Dupuis P; Deken-Delannoy V; Devos P; Duhamel A; Laffitte JJ; Dequiedt P; Rémy J
    J Radiol; 2009 Mar; 90(3 Pt 1):287-98. PubMed ID: 19421113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and Risk Factors for Postcontrast Acute Kidney Injury in Survivors of Sudden Cardiac Arrest.
    Petek BJ; Bravo PE; Kim F; de Boer IH; Kudenchuk PJ; Shuman WP; Gunn ML; Carlbom DJ; Gill EA; Maynard C; Branch KR
    Ann Emerg Med; 2016 Apr; 67(4):469-476.e1. PubMed ID: 26363571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety of gadolinium in patients with stage 3 and 4 renal failure.
    Ergün I; Keven K; Uruç I; Ekmekçi Y; Canbakan B; Erden I; Karatan O
    Nephrol Dial Transplant; 2006 Mar; 21(3):697-700. PubMed ID: 16326736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
    Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
    Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
    Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
    J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis.
    Christensen KN; Lee CU; Hanley MM; Leung N; Moyer TP; Pittelkow MR
    J Am Acad Dermatol; 2011 Jan; 64(1):91-6. PubMed ID: 21036418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.